Dey
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Dey sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
Dey: 21 sponsored US clinical trials, none currently recruiting.
Dey sponsors 21 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 21 completed. 7 of these trials are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Asthma, with 5 trials.
Top-decile sponsor footprint
Dey ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
21 total, page 1 of 1
12-Week Study in Adult Subjects With Asthma
NCT01516073
A 12-Week Study in Adult Subjects With Asthma
NCT01516086
Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)
NCT01488019
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01168310
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
NCT01113593
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
NCT00774761
Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis
NCT00552773
A Crossover Study in the Treatment of Patients With COPD
NCT00462540
Study in Subjects Greater Than 40 Years of Age With COPD
NCT00507234
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
NCT00403286
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
NCT00308191
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
NCT00280371
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD
NCT00215436
Study in Patients With Asthma
NCT00215358
Study in Patients With Asthma
NCT00215371
Study in Patients With Asthma
NCT00215410
Study in Patients With Asthma
NCT00215397
A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.
NCT00280358
Study in Patients With COPD
NCT00215384
Study in Patients With COPD
NCT00215423
Study in Patients With COPD
NCT00215449
How the Dey early-phase archive is shaped
21 indexed studies, none listed as recruiting (0% open); 21 completed (100%).
Phase mix: 7 late (III/IV) vs 13 early (I/II) (early-phase heavy).
Top condition: Asthma (5 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Dey: archived-pipeline peers nationwide
Peers matched on 21 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Dey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 archived trials
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Dey page
21 registered trials is a research-attention snapshot, not an endorsement of Dey or any single study.
- None of Dey's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Asthma is the condition Dey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Asthma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Dey pipeline card: 21 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.